Is bacterial vaginosis (BV) a sexually transmitted infection (STI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Bacterial Vaginosis Sexually Transmitted?

Bacterial vaginosis is not a classic sexually transmitted infection, though it is clearly associated with sexual activity and behaviors. 1

The Paradox of BV and Sexual Activity

BV occupies a unique position that distinguishes it from traditional STIs:

  • Women who have never been sexually active rarely develop BV, establishing a clear link between sexual behavior and disease occurrence 2, 1
  • However, BV does not behave like a typical STI because treating male sexual partners has consistently failed to prevent recurrence in women across multiple decades of CDC guidelines 2, 1
  • Male partners are not symptomatic, and their treatment does not alter the clinical course or reduce relapse rates in affected women 1

The CDC's Official Position

The Centers for Disease Control and Prevention has maintained a consistent stance across multiple guideline iterations:

  • BV is associated with having multiple sex partners, but it remains unclear whether this results from acquisition of a sexually transmitted pathogen 2
  • The CDC explicitly recommends against routinely treating male partners of women with BV 1
  • BV results from replacement of normal H₂O₂-producing Lactobacillus species with high concentrations of anaerobic bacteria, G. vaginalis, and Mycoplasma hominis 2, 3

Sexual Behaviors Associated with BV

The relationship between BV and sexual activity is more nuanced than simple transmission:

  • BV is associated with indicators of high-risk sexual behavior including new sexual partners, greater number of partners, and increased lifetime sexual partners 4
  • BV is common among women-who-have-sex-with-women, relating at least in part to non-coital sexual behaviors 5
  • Non-penetrative sexual contact (digito-genital contact, oral sex) also enhances BV risk, indicating that sex per se—but not necessarily coital transmission—is involved 5
  • Frequency of intercourse appears to be a critical factor, possibly through mechanical transfer of perineal enteric bacteria or alkalinization of the vaginal environment 5

The "Sexually Enhanced Disease" Model

Rather than a sexually transmitted infection, BV may be better conceptualized as a "sexually enhanced disease" (SED) 5:

  • Sexual activity may mechanically transfer perineal enteric bacteria into the vagina 5
  • Unprotected intercourse causes alkalinization of the vaginal environment, enhancing the shift from lactobacilli-dominated flora to BV-associated flora 5
  • Condom use is slightly protective, supporting the mechanical and pH-related mechanisms rather than pathogen transmission 5

Clinical Implications

The primary treatment goal is to relieve vaginal symptoms in the affected woman, not to treat partners 1:

  • Up to 50% of women with BV are asymptomatic 3, 1
  • BV has a high recurrence rate (50-80% within one year) regardless of partner treatment 3, 1
  • Treatment focuses on metronidazole 500 mg orally twice daily for 7 days or alternative regimens 6, 3

Important Caveats

  • BV rarely occurs in prepubertal girls and postmenopausal women, suggesting hormonal components in its etiology 7
  • The reservoir for BV-associated organisms is probably the distal intestinal tract and mouth, not sexual partners 7
  • G. vaginalis carriage has been observed among adolescent, sexually non-experienced girls, contradicting that sexual transmission is a necessary prerequisite 5

References

Guideline

Bacterial Vaginosis Transmission and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cytolytic Vaginosis and Bacterial Vaginosis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Vaginitis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[The definition and epidemiology of bacterial vaginosis].

Revue francaise de gynecologie et d'obstetrique, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.